Ark Genomic Revolution UCITS ETF (SWX:ARKG)
Switzerland · Delayed Price · Currency is CHF 5.14
-0.40 (-7.19%)
At close: Jun 5, 2026
51.94% (1Y)
| Assets | 46.35M |
| Expense Ratio | 0.79% |
| PE Ratio | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +51.94% |
| Volume | 5,085 |
| Open | 5.38 |
| Previous Close | 5.54 |
| Day's Range | 5.14 - 5.39 |
| 52-Week Low | 3.38 |
| 52-Week High | 5.54 |
| Beta | n/a |
| Holdings | 32 |
| Inception Date | Apr 12, 2024 |
About ARKG
AAKG.DE was created on 2024-04-12 by ARK. The fund's investment portfolio concentrates primarily on theme equity. The investment objective of the Fund is to generate long term capital growth (5 years or more)
Asset Class Equity
Category Theme
Stock Exchange SIX Swiss Exchange
Ticker Symbol ARKG
Provider ARK
Performance
ARKG had a total return of 51.94% in the past year, including dividends. Since the fund's inception, the average annual return has been 16.29%.
Top 10 Holdings
59.28% of assets| Name | Symbol | Weight |
|---|---|---|
| Twist Bioscience Corporation | TWST | 9.59% |
| CRISPR Therapeutics AG | CRSP | 7.52% |
| Tempus AI, Inc. | TEM | 7.26% |
| Personalis, Inc. | PSNL | 6.22% |
| Absci Corporation | ABSI | 5.87% |
| 10x Genomics, Inc. | TXG | 4.93% |
| Illumina, Inc. | ILMN | 4.85% |
| Beam Therapeutics Inc. | BEAM | 4.72% |
| Intellia Therapeutics, Inc. | NTLA | 4.19% |
| Natera, Inc. | NTRA | 4.12% |